FCB Health New York names executive creative director
Laura Mizrahi has been named executive creative director by FCB Health New York, a pre-eminent healthcare communications network. Most recently, she had led the New York creative department at Razorfish Health.
Akili appoints chief marketing officer
Meghan Rivera has been appointed chief marketing officer by Akili, a developer of video game-based digital medical treatments. Previously, she was an executive at AMAG Pharmaceuticals.
Micron Medical appoints chief executive officer
Dr. Mark Landy has been appointed chief executive officer by Micron Medical, a privately held medical device manufacturer focused on urological conditions. Landy, who also is joining the company’s board of directors, had previously been executive vice president and chief strategy officer at MiMedx.
Intra-Cellular Therapies promotes chief medical officer
Dr. Suresh Durgam has been promoted to the position of chief medical officer by Intra-Cellular Therapies, a developer of therapies for central nervous system disorders. Previously, he had been senior vice president, late stage clinical development and medical affairs.
Exscientia appoints chairman of the board
Dr. David Nicholson has been appointed chairman of the board of directors by Exscientia, a pre-eminent AI drug discovery company. Before that he had been chief R&D officer at Allergan.
Caris Life Sciences names chief business officer
Brian Lamon, Ph.D., has been named chief business officer, head of BioPharma business development, by Caris Life Sciences, a developer of molecular profiling solutions. He previously worked for Bristol Myers Squibb as vice president, development lead, genitourinary, malignancies, oncology development.
Neuronetics appoints vice president of sales
Sara Grubbs has been appointed vice president, sales, by medical technology company Neuronetics. Previously, she held sales leadership and management roles with Revance, Aesthetics, Allergan, Ulthera and Solta Medical.
Elucida appoints chief medical officer
Dr. Eliel Bayever has been appointed chief medical officer by Elucida Oncology,